Neuroprotective effect of lamotrigine and MK-801 on rat brain lesions induced by 3-nitropropionic acid: evaluation by magnetic resonance imaging and in vivo proton magnetic resonance spectroscopy.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Neuroscience

• Publication date

  1999-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0306-4522(99)00410-8PMID 10619465
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nature and distribution of brain lesions in rats intoxicated with 3-nitropropionic acid: A type of hypoxic (energy deficient) brain damage

  2004cited by this paper
• Temporal evolution of 3-nitropropionic acid-induced neurodegeneration in the rat brain by T2-weighted, diffusion-weighted, and perfusion magnetic resonance imaging.

  1999cited by this paper
• Partial Inhibition of Brain Succinate Dehydrogenase by 3‐Nitropropionic Acid Is Sufficient to Initiate Striatal Degeneration in Rat

  1998cited by this paper
• Lamotrigine inhibits depolarization‐evoked Ca++ influx in dissociated amygdala neurons

  1998cited by this paper
• 6-Hydroxydopamine injections into the nigrostriatal pathway attenuate striatal malonate and 3-nitropropionic acid lesions.

  1998cited by this paper
• Quantitative proton-decoupled 31P MRS and 1H MRS in the evaluation of Huntington's and Parkinson's diseases

  1998cited by this paper
• 1H NMR spectroscopy studies of Huntington's disease

  1998cited by this paper
• Combined PET/MRS brain studies show dynamic and long-term physiological changes in a primate model of Parkinson disease

  1998cited by this paper
• Metabolic compromise with systemic 3-nitropropionic acid produces striatal apoptosis in Sprague-Dawley rats but not in BALB/c ByJ mice.

  1998cited by this paper
• Evaluation of Focal Cerebral Ischemia in Rats by Magnetic Resonance Imaging and Immunohistochemical Analyses

  1998cited by this paper
• Apoptosis in the striatum of rats following intraperitoneal injection of 3-nitropropionic acid.

  1997cited by this paper
• Mechanisms of Cell Death Induced by the Mitochondrial Toxin 3-Nitropropionic Acid: Acute Excitotoxic Necrosis and Delayed Apoptosis

  1997cited by this paper
• Lamotrigine protects hippocampal CA1 neurons from ischemic damage after cardiac arrest.

  1997cited by this paper
• MK-801 neurotoxicity in the guinea pig cerebral cortex: susceptibility and regional differences compared with the rat.

  1997cited by this paper
• 3-Nitropropionic acid animal model and Huntington's disease.

  1997cited by this paper
• Metabolic alterations produced by 3-nitropropionic acid in rat striata and cultured astrocytes: quantitative in vitro 1H nuclear magnetic resonance spectroscopy and biochemical characterization.

  1997cited by this paper
• Acute 3-nitropropionic acid intoxication induces striatal astrocytic cell death and dysfunction of the blood-brain barrier: involvement of dopamine toxicity.

  1997cited by this paper
• Mechanisms of action of new antiepileptic drugs.

  1997cited by this paper
• Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid.

  1997cited by this paper
• Localized Proton Magnetic Resonance Spectroscopy of Brain Disorders in Childhood

  1997cited by this paper
• MK‐801 neurotoxicity in the guinea pig cerebral cortex: Susceptibility and regional differences compared with the rat

  1997cited by this paper
• Neuronal Loss and Cytoskeletal Disruption Following Intrahippocampal Administration of the Metabolic Inhibitor Malonate: Lack of Protection by MK‐801

  1996cited by this paper
• MK‐801 induces apoptotic neuronal death in the rat retrosplenial cortex: Prevention by cycloheximide and R(−)‐2‐Hexyl‐N‐ Methylpropargylamine

  1996cited by this paper
• Neuroprotective strategies for treatment of lesions produced by mitochondrial toxins: implications for neurodegenerative diseases.

  1996cited by this paper
• Clinical applications of proton MR spectroscopy.

  1996cited by this paper
• Non-Invasive Neurochemical Analysis of Focal Excitotoxic Lesions in Models of Neurodegenerative Illness Using Spectroscopic Imaging

  1996cited by this paper
• Proton MR spectroscopy of the brain: clinically useful information obtained in assessing CNS diseases in children.

  1996cited by this paper
• In vivo 1H MRS choline: correlation with in vitro chemistry/histology.

  1996cited by this paper
• Inhibition of N‐type calcium currents by lamotrigine in rat amygdalar neurones

  1996cited by this paper
• Lamotrigine inhibits Ca2+ currents in cortical neurons: functional implications.

  1996cited by this paper
• Oxidative stress and mitochondrial dysfunction in neurodegeneration

  1996cited by this paper
• Mitochondrial defect in Huntington's disease caudate nucleus

  1996cited by this paper
• Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates.

  1995cited by this paper
• Chronically administered 3-nitropropionic acid induces striatal lesions attributed to dysfunction of the blood-brain barrier.

  1995cited by this paper
• Quantitative in vivo 1H nuclear magnetic resonance spectroscopic imaging of neuronal loss in rat brain.

  1995cited by this paper
• Reactive gliosis induced by MK-801 in the rat posterior cingulate/retrosplenial cortex: GFAP evaluation by sandwich ELISA and immunocytochemistry.

  1995cited by this paper
• Intrastriatal injections of the succinate dehydrogenase inhibitor, malonate, cause a rise in extracellular amino acids that is blocked by MK-801.

  1995cited by this paper
• Clinical MR spectroscopy: fundamentals, current applications, and future potential.

  1995cited by this paper
• 3-Nitropropionic acid induces apoptosis in cultured striatal and cortical neurons.

  1995cited by this paper
• Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function.

  1995cited by this paper
• Reactive gliosis induced by MK-801 in the rat posterior cingulate/retrosplenial cortex: GFAP evaluation by sandwich ELISA and immunocytochemistry.

  1995cited by this paper
• Mitochondrial dysfunction in movement disorders

  1994cited by this paper
• Oxidative stress, glutamate, and neurodegenerative disorders.

  1993cited by this paper
• Mitochondrial impairment reduces the threshold for in vivo NMDA-mediated neuronal death in the striatum.

  1993cited by this paper
• Do defecs in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases

  1993cited by this paper
• Proton MR spectroscopic characterization of differences in regional brain metabolic abnormalities in mitochondrial encephalomyopathies

  1993cited by this paper
• Age‐Dependent Vulnerability of the Striatum to the Mitochondrial Toxin 3‐Nitropropionic Acid

  1993cited by this paper
• Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types

  1993cited by this paper
• Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-D-aspartate (NMDA) antagonist MK(+)801 (dizocilpine maleate): a light and electron microscopic evaluation of the rat retrosplenial cortex.

  1993cited by this paper
• Antagonism of the NMDA and non-NMDA receptors in global versus focal brain ischemia.

  1993cited by this paper
• Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid

  1993cited by this paper
• Evaluation of quinolinic acid induced excitotoxic neurodegeneration in rat striatum by quantitative magnetic resonance imaging in vivo.

  1992cited by this paper
• Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?

  1992cited by this paper
• Dopaminergic modulation of excitotoxicity in rat striatum: Evidence from nigrostriatal lesions

  1991cited by this paper
• Biochemical considerations in 1H spectroscopy. Glutamate and glutamine; Myo‐inositol and related metabolites

  1991cited by this paper
• Mechanisms underlying initiation of excitotoxicity associated with metabolic inhibition.

  1991cited by this paper
• Neurochemical and Behavioral Aspects of Lamotrigine

  1991cited by this paper
• Quantitative proton magnetic resonance imaging in focal cerebral ischemia in rat brain.

  1991cited by this paper
• Cerebral hypoxia: some new approaches and unanswered questions

  1990cited by this paper
• Phencyclidine, dizocilpine, and cerebrocortical neurons.

  1990cited by this paper
• Chemically induced hypoglycemia and anoxia: relationship to glutamate receptor-mediated toxicity in retina.

  1990cited by this paper
• 2D COSY 1H NMR: a new tool for studying in situ brain metabolism in the living animal

  1990cited by this paper
• Excitotoxicity of NMDA and kainic acid is modulated by nigrostriatal dopaminergic fibres.

  1989cited by this paper
• Neurotoxicity at the N‐Methyl‐D‐Aspartate Receptor in Energy‐Compromised Neurons An Hypothesis for Cell Death in Aging and Disease

  1989cited by this paper
• Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced.

  1988cited by this paper
• Distribution of N-methyl-D-aspartate-sensitive L-[3H]glutamate-binding sites in rat brain

  1985cited by this paper
• Autoradiographic characterization of N-methyl-D-aspartate-, quisqualate- and kainate-sensitive glutamate binding sites.

  1985cited by this paper
• Histochemical localization of cytochrome oxidase in the hippocampus: correlation with specific neuronal types and afferent pathways.

  1982cited by this paper
• Inactivation of succinate dehydrogenase by 3-nitropropionate.

  1979cited by this paper
• HISTOCHEMICAL INVESTIGATIONS ON SUCCINIC DEHYDROGENASE IN THE CENTRAL NERVOUS SYSTEM—V THE DIENCEPHALON AND BASAL TELENCEPHALIC CENTRES OF THE GUINEA PIG

  1961cited by this paper
• HISTOCHEMICAL INVESTIGATIONS ON SUCCINIC DEHYDROGENASE IN THE CENTRAL NERVOUS SYSTEM‐III

  1959cited by this paper

• Performance of the prospective T2 MRI biomarker of neurotoxicity in a trimethyltin model in rats at 7 T.

  2023cites this paper
• Outcome of epilepsy in patients with mitochondrial disorders: Phenotype genotype and magnetic resonance imaging correlations.

  2018cites this paper
• A pharmacological overview of lamotrigine for the treatment of epilepsy

  2016cites this paper
• Alterations of cerebral glutamate in the euthymic state of patients with bipolar disorder.

  2015cites this paper
• Efficacy of Retigabine on Acute Limbic Seizures in Adult Rats

  2015cites this paper
• NMRI Methods in Psychoneuropharmacology

  2015cites this paper
• Autophagy as a Neuroprotective Mechanism Against 3-Nitropropionic Acid-Induced Murine Astrocyte Cell Death

  2013cites this paper
• Review article Mitochondrial disease and epilepsy q

  2013cites this paper
• Selected classical and novel antiepileptic drugs – mechanisms of action, neuroprotection, and effectiveness in epileptic and non-epileptic conditions

  2013cites this paper
• Mitochondrial disease and epilepsy.

  2013cites this paper
• A Rat Model of Hemidystonia Induced by 3-Nitropropionic Acid

  2013cites this paper
• Mitochondrial diseases and epilepsy

  2012cites this paper
• Possible GABAergic mechanism in the neuroprotective effect of gabapentin and lamotrigine against 3-nitropropionic acid induced neurotoxicity.

  2012cites this paper
• Animal Models of Dementia

  2011cites this paper
• Validation of Dementia Models Employing Neuroimaging Techniques

  2011cites this paper
• Neuroprotective effect of naringin, a dietary flavonoid against 3-nitropropionic acid-induced neuronal apoptosis.

  2011cites this paper
• Lycopene prevents 3-nitropropionic acid-induced mitochondrial oxidative stress and dysfunctions in nervous system.

  2010cites this paper
• Neuroprotection in Bipolar Depression

  2010cites this paper
• Longitudinal MRI and MRSI characterization of the quinolinic acid rat model for excitotoxicity: peculiar apparent diffusion coefficients and recovery of N‐acetyl aspartate levels

  2010cites this paper
• Neuroprotective and neurorestorative strategies for neuronal injury

  2009cites this paper
• Metabonomic Characterization of the 3-Nitropropionic Acid Rat Model of Huntington’s Disease

  2009cites this paper
• Neuroprotective potential of ionotropic glutamate receptor antagonists

  2009cites this paper
• Basal ganglia neuroprotection with anticonvulsants after energy stress: a comparative study

  2009influential citation
• Altered Open Field Behavior in Rats Induced by Acute Administration of 3-Nitropropionic Acid: Possible Glutamatergic and Dopaminergic Involvement

  2009cites this paper
• Antiepileptic medications in the treatment of neuropsychiatric symptoms associated with traumatic brain injury

  2008cites this paper
• Progress in neuroprotective strategies for preventing epilepsy.

  2008cites this paper
• Neuroprotection of lamotrigine on hypoxic-ischemic brain damage in neonatal rats: Relations to administration time and doses

  2008cites this paper
• Resistance to kynurenic acid of the NMDA receptor-dependent toxicity of 3-nitropropionic acid and cyanide in cerebellar granule neurons.

  2008cites this paper
• LAMOTRIGINE REDUCES INTESTINAL I/R INJURY IN THE RAT

  2007cites this paper
• Multiparametric MRI evaluation of kainic acid-induced neuronal activation in rat hippocampus.

  2007cites this paper
• Increased Anterior Cingulate/Medial Prefrontal Cortical Glutamate and Creatine in Bipolar Depression

  2007cites this paper
• [Neuroprotection in perinatal hypoxic-ischemic encephalopathy. Effective treatment and future perspectives].

  2007cites this paper
• Studies on the neurobehavioural toxic effects of the mitochondrial toxin, 3-nitropropionic acid

  2007cites this paper
• Lamotrigine Is Neuroprotective in the Energy Deficiency Model of MPTP Intoxicated Mice

  2007cites this paper
• Application of MRS to mouse models of neurodegenerative illness

  2007cites this paper
• The role of excitotoxicity in neurodegeneration.

  2006cites this paper
• Lamotrigine suppresses neurophysiological responses to somatosensory stimulation in the rodent

  2006cites this paper
• Oxidative stress and the viability of osteoblasts and cerebellar granule neurones.

  2006cites this paper
• Memantine reduces striatal cell death with decreasing calpain level in 3-nitropropionic model of Huntington's disease.

  2006cites this paper
• 3‐Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease

  2005cites this paper
• Antiepileptic drugs and neuroprotection: current status and future roles.

  2005cites this paper
• Neurodegenerative Diseases: Magnetic resonance spectroscopy of neurodegenerative illness

  2005cites this paper
• Excitatory amino acid neurotransmission.

  2005cites this paper
• Protective effects of ginseng components in a rodent model of neurodegeneration

  2005cites this paper
• Treatment options for status epilepticus.

  2005cites this paper
• 3-Nitropropionic Acid Model of Metabolic Stress

  2005cites this paper
• Animal Models of Neurological Disorders

  2005cites this paper
• Mitochondrial Inhibition and Oxidative Stress: Reciprocating Players in Neurodegeneration

  2005cites this paper
• LXIXth Annual Meeting of the Hungarian Physiological Society.

  2005cites this paper
• Effect of lamotrigine treatment on epileptogenesis: an experimental study in rat.

  2004cites this paper
• Effect of nicotine on 3-nitropropionic acid-induced oxidative stress in synaptosomes.

  2004cites this paper
• Magnetic resonance imaging and spectroscopy in assessing 3-nitropropionic acid-induced brain lesions: an animal model of Huntington's disease.

  2004cites this paper
• Treatment options for status epilepticus.

  2003cites this paper
• Creatine protects against the convulsive behavior and lactate production elicited by the intrastriatal injection of methylmalonate.

  2003cites this paper
• Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria

  2003cites this paper
• ADJUNCTS TO IMPROVE NEUROLOGICAL OUTCOME FOLLOWING HYPOTHERMIC

  2003cites this paper
• The promise of new antiepileptic drugs.

  2002cites this paper
• Lamotrigine plus leukocyte filtration as a neuroprotective strategy in experimental hypothermic circulatory arrest.

  2002cites this paper
• The mechanisms of neuronal death produced by mitochondrial toxin 3-nitropropionic acid: the roles of N-methyl-D-aspartate glutamate receptors and mitochondrial calcium overload.

  2002cites this paper
• Progress report on new antiepileptic drugs: a summary of the Sixth Eilat Conference (EILAT VI).

  2002cites this paper
• Acute and chronic alterations in calcium homeostasis in 3-nitropropionic acid-treated human NT2-N neurons.

  2002cites this paper
• Protecting the term newborn brain following hypoxia–ischaemia

  2002cites this paper
• ADJUNCTS TO IMPROVE NEUROLOGICAL OUTCOME FOLLOWING HYPOTHERMIC CIRCULATORY ARREST

  2002cites this paper
• Involvement of Superoxide in Excitotoxicity and DNA Fragmentation in Striatal Vulnerability in Mice after Treatment with the Mitochondrial Toxin, 3-Nitropropionic Acid

  2002cites this paper
• Orphenadrine prevents 3‐nitropropionic acid‐induced neurotoxicity in vitro and in vivo

  2001cites this paper
• Biochemical and reperfusion targeting strategies to improve brain protection during prolonged hypothermic circulatory arrest

  2001cites this paper
• [Lamotrigine in the treatment of mental disorders].

  2001cites this paper
• N‐Acetylaspartate, a marker of both cellular dysfunction and neuronal loss: its relevance to studies of acute brain injury

  2001cites this paper
• Lamotrigine

  2001cites this paper
• Expression of Brain-Derived Neurotrophic Factor in Cortical Neurons Is Regulated by Striatal Target Area

  2001cites this paper
• Effect of lamotrigine treatment on status epilepticus-induced neuronal damage and memory impairment in rat.

  2001cites this paper
• A bile acid protects against motor and cognitive deficits and reduces striatal degeneration in the 3-nitropropionic acid model of Huntington's disease.

  2001cites this paper
• Current awareness in NMR in biomedicine

  2000cites this paper